Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 May 2026 for Indivior Pharmaceuticals, Inc., €36k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Juliet Thompson: trading record in brief
Juliet Thompson (senior executive) discloses dealings in Indivior Pharmaceuticals, Inc. to SEC (Form 4). Between 26 January 2026 and 12 May 2026, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 14 May 2026, reports a share grant of €36k in Indivior Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Juliet Thompson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,117 shares@ US$38.280.0008% mcap100.0% of flowCommon StockSEC:0001715258-26-000007:0
3,722 shares0Common StockSEC:0001715258-26-000004:0
2 of 2 declarations
